Glecaprevir, also known as ABT-493 and A-1282576, is a NS 3/4A inhibitor potentially for the treatment of HCV
Or, Yat Sun; Ma, Jun; Wang, Guoqiang; Long, Jiang; Wang, Bin. Preparation of macrocycles, especially proline-containing cyclic peptides, as hepatitis C virus (HCV) NS3-NS4A protease inhibitors. US 20120070416 (Assignee Enanta Pharmaceuticals, Inc., USA)
Ye, Fangguo; Zeng, Qingfeng; Long, Shuangxi; Liu, Qingqing. Preparation of Glecaprevir. CN 108329332. (Assignee Anhui Twisun Hi-tech Pharmaceutical Co., Ltd., Peop. Rep. China)
